Stockscreener 앱 받기
7.19
7.70%
-0.60
Rxsight Inc 주식(RXST)의 최신 뉴스
Needham & Company LLC Cuts RxSight (NASDAQ:RXST) Price Target to $11.00 - Defense World
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Is RxSight Inc. building a consolidation baseFree Buy Low Sell High Stock Watch - Newser
Should you hold or exit RxSight Inc. nowStable Swing Setup with Safety Analysis - Newser
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.
RXST Investors Have Opportunity To Lead RxSight, Inc. Securities Fraud Lawsuit - Barchart.com
Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - PR Newswire
RXST NEWS: Did RxSight, Inc. Mislead Investors? Contact BFA Law by September 22 Class Action Deadline (NASDAQ:RXST) - GlobeNewswire Inc.
Automated trading signals detected on RxSight Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
RxSight's Strategic Reinvention: Can International Expansion and Product Innovation Justify a Re-Rating? - AInvest
Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire
Investors in RxSight, Inc. (RXST): Protect Your RightsContact Levi & Korsinsky Before September 22, 2025 - ACCESS Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages RxSight, Inc. - GlobeNewswire
UBS Adjusts RxSight Price Target to $8 From $16, Maintains Neutral Rating - MarketScreener
RxSight stock price target cut by UBS to $8 on weak LDD placements - Investing.com
RxSight Inc. (RXST) PT Lowered to $8 at UBS - StreetInsider
Earnings call transcript: Rxsight Q2 2025 reports wider loss, stock rises - Investing.com
RxSight, Inc. Reports Q2 2025 Financial Results - TipRanks
RxSight’s Revenue Slips As Losses Grow But Margins Hold Steady - Finimize
RxSight, Inc. Presents Second Quarter 2025 Revenue, Reiterates Full-Year Guidance - VisionMonday.com
RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Rxsight earnings missed by $0.10, revenue fell short of estimates - Investing.com Canada
RxSight, Inc. (RXST) Misses Q2 EPS by 10c, provides guidance - StreetInsider
Investors in RxSight, Inc. Should Contact The Gross Law - GlobeNewswire
RxSight, Inc. Reports Second Quarter 2025 Financial Results - The Manila Times
RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost - GlobeNewswire
Investors Urged to Contact Levi & Korsinsky for Information Before September 22, 2025RxSight, Inc. (RXST) - ACCESS Newswire
Investors Don't See Light At End Of RxSight, Inc.'s (NASDAQ:RXST) Tunnel And Push Stock Down 39% - simplywall.st
RxSight, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationRXST - PR Newswire
RXST SHAREHOLDERS: RxSight, Inc. Stock Drop Triggers - GlobeNewswire
Join Class Action to Recover Losses from RxSight, Inc. (RXST)Contact Levi & Korsinsky Before September 22, 2025 - TradingView
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Lost Money on RxSight, Inc. (RXST)? Join Class Action Before September 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
Technical signs of recovery in RxSight Inc.Conservative Equity Setup with Signal Analysis - Newser
Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire
RXST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
RxSight Expands Board with New Director Appointment - The Globe and Mail
Levi & Korsinsky Notifies RxSight, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – RXST - GlobeNewswire
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights - Benzinga
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. LawsuitRXST - PR Newswire
RXST CLASS ACTION: RxSight, Inc. Investors that Lost Money - GlobeNewswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages RxSight, - GlobeNewswire
Using R and stats models for RxSight Inc. forecastingTrade Flow Monitor with Volume Tracker - Newser
RXST LEGAL NOTICE: BFA Law Reminds RxSight, Inc. Investors with Losses of the Imminent September 22 Securities Class Action Deadline - Newsfile
RXSIGHT, INC. (NASDAQ: RXST) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - PR Newswire
Class Action Filed Against RxSight, Inc. (RXST)September 22, 2025 Deadline to Join – Contact The Gross Law Firm - GlobeNewswire
RxSight (RXST) adds ex-Axonics CEO Raymond Cohen to Board | RXST SEC FilingForm 8-K - Stock Titan
RxSight (RXST) adds ex-Axonics CEO Raymond Cohen to Board | GBCI SEC FilingForm S-8 - Stock Titan
Shareholders who lost money on their RxSight, Inc. (NASDAQ: - GlobeNewswire
RxSight Appoints Raymond Cohen to Board of Directors - Orange County Business Journal
Lost Money on RxSight, Inc. (RXST)? Contact Levi & Korsinsky to Join Class Action Before September 22, 2025 - ACCESS Newswire
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
RXST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - PR Newswire
RxSight Inc. stock outlook for YEARDaily Trade Monitor with Pattern Alerts - Newser
The Gross Law Firm Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - PR Newswire
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors - GlobeNewswire
RxSight Taps Turnaround Expert Who Led $3.7B Axonics Exit to Drive Growth Strategy - Stock Titan
1.17%
자본화:
|
볼륨(24시간):